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Abstract
Background: Both tuberculous and non-tuberculous mycobacteria can cause infection in nonhuman primates
(NHP), indicating the existence of potential zoonotic transmission between these animals and visitors to zoos or
animal handlers in primate facilities. Screening of mycobacterial infections in NHP is traditionally done by
tuberculin skin test (TST), which is unable to distinguish between pathogenic and non-pathogenic mycobacterial
infections. In this study, we investigated the use of ESAT-6 and CFP-10 for detection of mycobacterial infections
in a wild-caught baboon colony after one baboon died of tuberculosis (TB).
Methods:  Peripheral blood lymphocytes for interferon-gamma enzyme-linked immunospot assay (IFN-γ
ELISPOT) assay were obtained from TST positive baboons and those in contact with tuberculous baboons before
being euthanased, autopsied and lung tissues taken for histology and mycobacterial culture.
Results: Both ESAT-6 and CFP-10 IFN-γ ELISPOT assays were able to detect early M. tuberculosis but also M.
intracellulare infection. Although this indicates potential cross-reactivity with M. intracellulare antigens, the method
was able to distinguish M. bovis BCG vaccination from M. tuberculosis infection. This assay performed better than
the TST, which failed to detect one M. tuberculosis and two early M. intracellulare infections.
Conclusion: These results suggest that the IFN-γ ELISPOT assay could improve the detection of M tuberculosis
infections when screening NHP. There is some doubt, however, concerning specificity, as the assay scored
positive three animals infected with M. intracellulare.
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Background
The majority of the disease-causing species of the genus
Mycobacterium belong to two groups, the M. tuberculosis
complex (MTC) and the M. avium-intracellulare complex
(MAC). MTC comprises of M. tuberculosis, M. bovis, M afri-
canum  and the attenuated M. bovis bacille Calmette-
Guerin (BCG). With the exception of BCG, these species
are pathogenic and can cause tuberculosis (TB) in humans
and animals [1-3]. Disease caused by MTC pathogens is
characterised by tubercle formation in the infected tissues.
These bacteria are considered obligate intracellular patho-
gens and the most efficient mode of transmission is via
respiratory route [4]. In contrast, environmental myco-
bacteria have the capacity to survive and multiply under a
wide range of environmental conditions [5] and to inter-
act with a variety of environmental reservoirs, including
protozoa and insects [6]. The majority of environmental
mycobacteria are considered non-pathogenic. However,
members of MAC are capable of causing nontuberculous
infections and disease in a wide range of animal species
[5,6]. MAC comprises of two species, M. avium and M.
intracellulare, and although these species are considered
opportunistic pathogens, their role in human and animal
diseases and their pathogenic potential have become
increasingly recognised, especially in immunocompro-
mised persons with HIV-1 infection [7,8].
Non-human primates (NHP) are susceptible to infections
caused by members of MTC [9-13] and MAC [14,15],
including M. intracellulare [16,17], indicating the exist-
ence of potential zoonotic transmission between NHP
and visitors to zoos and game parks as well as animal han-
dlers and laboratory workers using biological products
from NHP. The tuberculin skin test (TST) is the traditional
in vivo screening test for detecting TB in NHP [18]. This
test utilizes PPDs, which are crude antigen preparations,
usually made from M. tuberculosis, M. bovis or M. avium. As
PPD contains cross-reactive antigens [19], a positive TST
could indicate tuberculous and non-tuberculous disease,
prior vaccination with BCG, or immune sensitisation with
non-pathogenic environmental mycobacteria. In addi-
tion, BCG vaccine vectors are increasingly being used in
NHP studies [20-23], making it important to distinguish
such vaccinations from natural pathogenic mycobacterial
infections.
The 6-kDa early secretory antigenic target (ESAT-6) and
culture filtrate protein 10 (CFP-10) are well defined myco-
bacterial proteins [24-26]. Both are low molecular-weight
proteins which are secreted in the culture filtrate by M.
tuberculosis and other pathogenic mycobacteria, including
M. bovis [27], following short-term axenic culture. These
proteins are absent from the genomes of all BCG sub-
strains and those of several non-pathogenic environmen-
tal mycobacteria including M. avium avium and M. avium
paratuberculosis [24,28]. Both ESAT-6 and CFP-10 induce
strong T-cell IFN-γ responses [27,29-31], prompting their
proposed use as diagnostic markers for M. tuberculosis and
M. bovis infections [25,32,33]. However, the presence of
ESAT-6 and CFP-10 orthologues in other mycobacterial
species, including non-pathogenic species such as M.
smegmatis and M. gastri [34] and environmental species
like M. flavescens [28] has raised some concerns regarding
the potential use of these antigens as diagnostic markers
[35]. Paradoxically, the presence of ESAT-6 and CFP-10 in
other mycobacterial species does not seem to confound
the detection of M. tuberculosis- and M. bovis-associated
specific responses in clinical and epidemiological practice
[29,30,32,36-38], although these studies were mostly per-
formed in low-incidence settings and patients may not
have had significant previous contact with non-tubercu-
lous mycobacteria. A study by Arend et al [39] showed that
when ESAT-6 and/or CFP-10 enzyme-linked immuno-
sorbent assay (ELISA) and enzyme-linked immunospot
assay (ELISPOT) were used to measure interferon-gamma
production, most M. kansasii- or M. marinum-infected
patients and several persons exposed to environmental
mycobacteria responded to ESAT-6 and/or CFP-10. IFN-γ
production by T cells from leprosy patients, TB patients
and unexposed controls in response to the M. leprae
homologue of CFP-10 also showed significant crossreac-
tivity with CFP-10 of M. tuberculosis [40].
In the present study, we evaluated ESAT-6 and CFP-10 for
use in the interferon-gamma (IFN-γ) ELISPOT assay for
diagnosis of mycobacterial infections in baboons held in
a research facility in South Africa after the death of one
baboon due to TB.
Methods
Baboons
Ninety wild-caught Chacma baboons (Papio ursinus) were
involved in this study. Of these, 34 baboons had been
newly introduced into the colony from the wild, while the
other 56, including the one that died of M. tuberculosis
infection, had been kept in the colony for over 3 years. Of
the 56 baboons, 10 had been sensitised to BCG by exper-
imental inoculation, 2 to 3 years prior to the current
study. Ethical approval for the experimentation on the
baboons was obtained from the Animal Ethics Committee
of the University of Cape Town.
Tuberculin Skin test
Baboons were anaesthetised with ketamine hydrochloride
(10 mg/kg body mass; intramuscular injection) and
injected intradermally with 100 μL (1000 IU in saline) of
bovine tuberculin PPD (Institute of Animal Science and
Health, Lelystad, The Netherlands) in the upper palpe-
brum of the eyelid. Reaction to tuberculin was checked by
visual observation at 24, 48 and 72 hours and interpretedBMC Microbiology 2008, 8:27 http://www.biomedcentral.com/1471-2180/8/27
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as TST positive or negative. The TST positivity reactions
comprised of erythema of palpebrum alone, various
degrees of erythema with minimum swelling or slight
swelling of palpebrum without erythema, and obvious
swelling of palpebrum with drooping of the eyelid or
swelling and/or necrosis of the palpebrum with eyelid
closed. Bruise-extravasation of blood associated with
injection of tuberculin or no detectable reaction on the
palpebrum were interpreted as TST negative.
IFN-γ ELISPOT assay
Peripheral blood mononuclear cells (PBMC) were iso-
lated from heparinised blood by standard Ficoll-gradient
centrifugation. Freshly isolated or cryo-preserved PBMC
were used in a standard IFN-γ ELISPOT assay as previously
described [41]. Briefly, ELISPOT plates (MultiScreen-IP,
Millipore) were coated overnight at 4°C with purified
anti-human IFN-γ monoclonal antibody (clone 1-D1K,
Mabtech). PBMC were incubated for 24 h at 37°C in trip-
licate at 200,000 cells per well with PPD (4 μg/mL), ESAT-
6 (4 μg/mL), or CFP-10 (4 μg/mL) as the stimulant in a
total volume of 0.1 mL. Triplicate wells with cells and
PHA (4 μg/mL) and culture medium alone, served as pos-
itive and background stimulation controls respectively.
The average of triplicate counts of IFN-γ spot forming cells
(SFC) was calculated for each stimulant and normalised
to 106 PBMC to give IFN-γ SFC/106 PBMC. The results
were reported as net IFN-γ SFC/106 PBMC after subtract-
ing the background SFC/106  PBMC obtained in the
absence of any stimulant (PBMC plus culture medium
alone).
To determine if a response was positive, a cut-off value
was established for PPD, ESAT-6 and CFP-10 using PBMC
from 27 TST negative healthy baboons whose background
response or response to ESAT-6 or CFP-10 was <50 IFN-γ
SFC/106 PBMC. The cut-off value was defined as the mean
net IFN-γ SFC/106 PBMC after subtracting the value of
background reaction plus 3 standard deviations of the
mean or twice the highest value of background reaction,
whichever was greater. The mean net responses plus three
standard deviations for PPD, ESAT-6 and CFP-10 were 8 +
35, 12 + 31 and 5 + 22 IFN-γ SFC/106 PBMC respectively
while the highest value of background reactions were 43,
35 and 30. Thus, the cut-off values for PPD, ESAT-6 and
CFP-10 were determined as 86, 70 and 60 IFN-γ SFC/106
PBMC, respectively. The mean background stimulation in
the absence of any stimulant and in response to the PHA
positive controls were 5 ± 4 and 1562 ± 697 SFC/106
PBMC respectively.
Euthanasia and necropsy
Baboons with a positive TST were euthanased for
necropsy using sodium pentobarbital (200 mg/kg body
mass). In addition, baboons that were caged adjacent to
those which were found to have tubercles at necropsy
(here referred to as contact baboons) were also eutha-
nased for necropsy. All the TST-positive baboons had
been kept in the colony for over 3 years while 6 of 8 con-
tact baboons were less than 3 months in the colony.
Before euthanasia, blood for PBMC isolation was col-
lected from these animals. Also, as part of ongoing
research, cryo-preserved PBMC were available from some
of these animals. Organs in the thoracic and abdominal
cavities were examined macroscopically for the presence
of tubercles, adhesions or enlargement and/or caseation
of lymph nodes. Samples for histology, mycobacteria-spe-
cific staining and culture were taken from the lung tissue
and/or bronchial lymph nodes (BLN).
Histology, ZN test and M. tuberculosis 
immunoperoxidase staining
Tissues were fixed in 10% buffered formalin and sent to a
veterinary pathologist (VetPath; Pretoria) for histological
examination, Ziehl-Neelsen (ZN) and M. tuberculosis
immunoperoxidase (MTIP) staining.
Mycobacteria culture and identification
Fresh tissues from the lung and/or BLN collected at
necropsy were cultured for mycobacterial culture, using
standard methods in the TB research laboratory of the
Stellenbosch University. Standard precautions were fol-
lowed to limit cross-contamination. All cultures were gen-
otyped by the IS6110  Restriction Fragment Length
Polymorphism (RFLP) method [42]. Isolates were also
typed according to the Mycobacterium tuberculosis complex
typing method developed in our laboratory [43]. Mycobac-
terium tuberculosis complex negative samples were further
subjected to a 5'-16S rRNA gene PCR-sequencing assay,
which is able to identify and speciate Mycobacterium spp.
[44,45]. Used in combination these methods would be
able to identify superinfections between mycobacterial
species of MTC and MAC.
Results
Tuberculin Skin test
Following the death of one baboon (B662) due to pulmo-
nary TB diagnosed at necropsy, the remaining 89 baboons
in the colony were screened for mycobacterial infection
using bovine PPD tuberculin. Initially, only eight
baboons tested positive, including three (B454, B536 &
B548) with known prior vaccination with BCG or recom-
binant BCG. One additional baboon (B369) tested posi-
tive three months after initially testing negative, resulting
in a total of nine tuberculin reactors (Figure 1 and Table
1). The test reaction ranged from severe (drooping of the
eyelid, necrosis of the palpebrum with eyelid completely
closed; B524, B531 & B629) to slight reactions (erythema
of palpebrum with minimal swelling; B369, B454, B536 &
B548). Reactions on eyelids of baboon B659 and B697BMC Microbiology 2008, 8:27 http://www.biomedcentral.com/1471-2180/8/27
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were moderate (obvious swelling of palpebrum without
drooping or necrosis).
Necropsy
The nine TST reactors and an additional eight contact
baboons were euthanased for necropsy and further inves-
tigations. Of the nine TST positive baboons, four had clas-
sical tubercles in the lungs including at least one caseous
BLN, one had a non-classical tubercle-like lesion (B697)
with an enlarged but not caseous BLN and four had no
macroscopic lesions (Table 1). Paradoxically, one of eight
TST negative baboons (B673) had a single caseous BLN
with no visible tubercles. The severity of lesions varied
widely, ranging from numerous small tubercles in the
lungs and one or more caseous BLN (B524, B531 and
B629) to just a single caseous BLN (B673). These macro-
scopic lesions were restricted to the pulmonary system.
Histology, ZN test and M. tuberculosis 
immunoperoxidase staining
As shown in the Table 1, necrotic granulomas and areas of
necrosis were found in the lung and BLN tissues of three
of nine TST positive baboons while other lesions such as
lymphocytic infiltration and granulomatous inflamma-
tion, suggestive of mycobacterial infection, were found in
four other TST reactors. Also, five of seven histologic
lesions were confirmed by ZN and MTIP staining. For the
TST negative baboons, only mild histological lesions were
found in four of eight baboons and one (B673) was posi-
tive by ZN and MTIP staining.
Mycobacterial culture and identification
Of the 17 baboons' specimens that were cultured, eight
yielded mycobacterial growth. M. tuberculosis was identi-
fied in five and M. intracellulare in three of these cultures
by PCR-based methods and 16S rRNA sequencing. M.
tuberculosis was cultured from four of the nine TST reactors
and one of eight TST negative baboons while M. intracel-
lulare was cultured from one TST reactor and two TST neg-
ative baboons (Figure 1 and Table 1). It was unlikely that
the culture of M. intracellulare represented laboratory
cross-contamination as this species is rarely identified in
sputum specimens routinely cultured in our laboratory.
No superinfection was detected in any of these samples.
Table 1: Summary of findings
TST 
status
Baboon 
number
IFN-γ ELISPOT 
(SFC/106 PBMC)#
Pathology (lungs and BLN) Special staining Mycobacteria 
culture
PPD ESAT6 CFP10 Necropsy Histopathology ZN MT IP
TST 
positive 
baboons
B454Ψ 902 774 157 Negative No granulomas; mild 
interstitial lymphocytic 
infiltration in BLN
+ (BLN only) Negative Negative
B524 2650 2163 2243 Several tubercles; caseous LN Multifocal necrogranulomas Negative + M. tuberculosis
B531 210 89 109 Several tubercles; caseous LN Multifocal necrogranulomas; 
caseous necrosis in BLN
++ M. tuberculosis
B536Ψ 743 20 11 Negative No granulomas; mild 
peribronchial fibrosis;
+ Negative Negative
B548Ψ ND ND ND Negative ND ND ND Negative
B629 736 448 1348 Several tubercles; caseous LN Multifocal necrogranulomas + Negative M. tuberculosis
B659 ND ND ND Single tubercle; single caseous LN ND ND ND M. tuberculosis
B697 1748 0 0 A single tubercle-like lesion; 
enlarged hilar LN
Multifocal areas of 
granulomatous pneumonia
Negative Negative Negative
B369* 1397 1192 1170 Negative No granumomas; focal 
hyperplasia in BLN
Negative Negative M. intracellulare
TST 
negative 
baboons
B630 0 35 48 Negative No granulomas; mild 
lymphatic hyperplasia in BLN
Negative Negative Negative
B673 ND ND ND Single caseous LN Multifocal mild pneumonitis + + M. tuberculosis
B679 0 67 109 Negative No granulomas; mild 
multifocal perivascular 
lymphocytic cuffing
Negative Negative Negative
B689 78 117 63 Negative Negative Negative Negative Negative
B694 0 86 66 Negative Mild granulomatous 
inflammation
Negative Negative M. intracellulare
B696 0 69 17 Negative Negative Negative Negative Negative
B704 2 28 33 Negative Negative Negative Negative Negative
B709 50 60 138 Negative Negative Negative Negative M. intracellulare
This table gives a summary of the major findings of the study. ND: not determined; BLN: bronchial lymph node; +: positive outcome; *: initially TST 
negative; Ψ: known prior vaccination with BCG or recombinant BCG; #: cut-off values for PPD, ESAT-6 & CFP-10 = 86, 70, & 60 SFC/106 
respectively (bold face indicate a positive response).BMC Microbiology 2008, 8:27 http://www.biomedcentral.com/1471-2180/8/27
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IFN-γ ELISPOT assay
PBMC were isolated from some baboons at the time of
TST or just before euthanasia for determination of IFN-γ
ELISPOT response to bovine PPD, ESAT-6 and CFP-10. As
shown in Figure 1 and Table 1, PPD ELISPOT test was pos-
itive for all TST positive reactors and negative for all TST
non-reactors, indicating agreement between these two
tests. However, two of the tuberculin reactors (B536 and
B697) were negative for both ESAT-6 and CFP-10 ELIS-
POT test. The mycobacterial culture in these animals was
also negative. The ESAT-6 and CFP-10 ELISPOT test was
positive for B454, another TST reactor which had previ-
Summary of the TST, ESAT-6 and CFP-10 IFN-γ ELISPOT assay and mycobacterial culture outcome Figure 1
Summary of the TST, ESAT-6 and CFP-10 IFN-γ ELISPOT assay and mycobacterial culture outcome. A flow 
diagram showing the outcome of tuberculin skin test (TST), ESAT-6 and CFP-10 IFN-γ ELISPOT assay and mycobacterial cul-
ture.
CULTURE CULTURE CULTURE CULTURE CULTURE CULTURE
POS NEG NEG POS NEG NEG POS NEG POS
(1baboon) (1 baboon) (2 baboons) (4 baboons) (1 baboon) (3 baboons) (2 baboons) (2 baboons) (1 baboon)
MTB MTB MI MI MTB
B659 B548 B536 B524 B369 B454 B630 B694 B679 B673
B697 B531 B696 B704 B689
B629 B704
KEY
TT Tuberculin skin test
POS Positive
NEG Negative
MTB Mycobacterium tuberculosis
MI Mycobacterium intracellulare
POS TT NEG TT
(17 baboons)
(9 baboons) (8 baboons)
(2 baboons)
NOT DONE
ELISPOT ELISPOT
DONE
(7 baboons)
NEG
ESAT6/CFP10
(2 baboons)
POS POS
ESAT6/CFP10
(4 baboons)
SUSPECTED MYCOBACTERIAL
ESAT6/CFP10
(5 baboons)
NEG
ESAT6/CFP10
(3 baboons)
INFECTION
ELISPOT
NOT DONE
(1 baboon)
ELISPOT
DONE
(7 baboons)BMC Microbiology 2008, 8:27 http://www.biomedcentral.com/1471-2180/8/27
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ously been vaccinated with BCG, although no mycobacte-
ria was isolated from tissues from this animal. The ESAT-
6 and CFP-10 ELISPOT test was also positive for B369,
which was initially TST negative and mycobacteria culture
positive for M. intracellulare. For the TST non-reactors,
ESAT-6 and CFP-10 ELISPOT test was positive for four
baboons, two (B694 and B709) from which M. intracellu-
lare was isolated. However, no mycobacteria was isolated
from the other two baboons (B679 and B689), which
were also positive by ESAT-6 and CFP-10 ELISPOT.
In an attempt to understand the kinetics of immune
responses to M. tuberculosis and M. intracellulare, we per-
formed retrospective measurements of T-cell IFN-γ
responses in an ELISPOT assay using cryo-preserved
PBMC, previously obtained from baboons B369 and
B662. As depicted in Figure 2, the responses to ESAT-6 for
B369 could be detected as early as 18 weeks before eutha-
nasia but the PPD (and CFP-10) responses were detecta-
ble only 6 weeks later. Thus, the TST was initially negative
at 16 weeks before euthanasia although the ELISPOT
assay value was above the positive cut-off value for ESAT-
6 (but not PPD and CFP-10). This delay in induction of a
PPD response was not observed for B662 that died of TB.
Discussion
The TST, which is a delayed-type hypersensitivity (DTH)
reaction, is partially T cell-mediated [46] and IFN-γ plays
a major role [47]. The major drawback of this test is the
inability to distinguish active pathogenic infection from
healthy carrier status, or from non-pathogenic exposure to
environmental mycobacteria or BCG. The majority of TB
outbreaks in NHP are associated with human contact or
TB infected animals and carcasses [9,10,12] and rarely
give rise to latent TB infection [11]. Thus, MTC infections
in NHP are considered progressive and almost always
fatal. However, infection with MAC is usually chronic [14-
17] and sometimes refractory to TST [16]. In order to
eliminate their zoonotic potential, early and reliable
detection of potential pathogenic mycobacterial infec-
tions, including members of MAC in the nonhuman pri-
mate colonies is crucial.
Both ESAT-6 and CFP-10 have been proposed as diagnos-
tic markers for pathogenic infection caused by M. tubercu-
losis  and  M. bovis in human and animals [25,31-33]
because they are well defined antigens [24-26], absent
from BCG vaccine strains and some non-pathogenic envi-
ronmental mycobacteria [28,36], and they associate in M.
tuberculosis-exposed people with a higher risk of develop-
ing active tuberculosis [29,30].
In our study, the IFN-γ ELISPOT response to ESAT-6,
CFP10 and PPD were compared to the TST. There was
concordance between the TST and PPD ELISPOT tests.
However the results for ESAT-6 and CFP-10 ELISPOT and
TST were discordant in two of seven TST-positive and four
of seven TST-negative animals. One of the two TST-posi-
tive but ESAT-6 and CFP-10 negative baboon (B536)
could be a result of previous exposure to BCG via inocula-
tion with a recombinant BCG vaccine 2–3 years previ-
ously, but the other baboon (B697) possibly represents
environmental sensitisation as this animal had been
caught from the wild less than 3 months before the test
and had no known exposure to BCG. This outcome dem-
onstrates that ESAT-6 and CFP-10 ELISPOT test is capable
of distinguishing BCG vaccination and environmental
exposure by non-pathogenic mycobacterial infection (or
TST false-positives) from TB disease. However, ESAT-6
and CFP-10 ELISPOT test for another TST-positive
baboon (B454) that had previously been vaccinated with
BCG, was not conclusive as no mycobacteria was isolated
from tissues from this animal. It was noteworthy that one
M. intracellulare infection (B369) was detected by both
TST and ESAT-6 and CFP-10 ELISPOT tests. Since the
methods used to identify and speciate the mycobacteria
excluded the possibility of superinfection with M. tubercu-
losis, this result suggests a cross-reactivity between M.
tuberculosis-derived ESAT-6 and CFP-10 antigens and M.
intracellulare. Paradoxically, TST failed to detect two other
M. intracellulare-infected baboons (B694 and B704), pos-
sibly because the stage of infection in these animals were
too early for the PPD-specific T responses to have devel-
oped.
Our data on the kinetics of immune responses induced by
M. tuberculosis and M. intracellulare show that induction of
PPD responses occurs much later than that of ESAT-6 in
case of M. intracellulare infection. Thus, it is possible for
TST to miss early M. intracellulare infection, as we
observed in this study. However, the isolation of M. intra-
cellulare from two other TST-negative but ESAT-6 and CFP-
10 ELISPOT-positive baboons (B694 and B709) casts
some doubt regarding the specificity of this ELIPOT test.
This needs to be resolved by further investigation using
larger sample sizes.
Although limited by the small sample size and an
assumed exposure in the in-contact baboons, the findings
in this study indicate that the ESAT-6 and CFP-10 ELIS-
POT assays were highly effective in detecting M. tuberculo-
sis and M. intracellulare infections (although the detection
of M. intracellulare was unsuspected and ostensibly indi-
cates cross-reactivity). Further, these results show the abil-
ity of this method to distinguish BCG vaccination from
infection with these mycobacteria. In addition, our results
show that the TST failed to detect two infections with M.
intracellulare and one infection with M. tuberculosis. We
further show that T-cell responses to ESAT-6 and CFP-10
develop much earlier than those of PPD, especially in M.BMC Microbiology 2008, 8:27 http://www.biomedcentral.com/1471-2180/8/27
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intracellulare  infection and hypothesise that this could
possibly facilitate earlier diagnosis of mycobacterial infec-
tion by ELISPOT test.
Conclusion
This study demonstrated that the traditional TST can man-
ifest significant false-negatives in screening for tuberculo-
sis in NHP while the ESAT-6 and CFP-10 ELISPOT assays
are highly effective in detecting M. tuberculosis and  M.
intracellulare infections, thus facilitating an improvement
in identifying and controlling a potential zoonotic trans-
mission hazard, especially where NHP are infected with
M. intracellulare. The study also presents the first evidence
of cross-reactivity between M. tuberculosis ESAT-6 and
CFP-10 and M. intracellulare antigens, where animals
infected with M. intracellulare react to ESAT-6 and CFP-10
of M. tuberculosis. Whilst this study may support the use of
an ESAT-6 or CFP-10 IFN-γ ELISPOT assay to screen for
tuberculosis in NHP facilities, a positive result may arise
from infection by mycobacteria other than M. tuberculosis.
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IFN-γ ELISPOT responses to mycobacterial proteins at various times prior to death (B662) or euthanasia (B369) Figure 2
IFN-γ ELISPOT responses to mycobacterial proteins at various times prior to death (B662) or euthanasia 
(B369). Three mycobacterial antigen preparations (bovine PPD, ESAT-6 and CFP-10) were used in IFN-γ ELISPOT assay using 
cryo-preserved PBMC from baboon B662 (infected with M. tuberculosis) and B369 (infected with M. intracellulare). The IFN-γ 
response to each protein was determined by subtracting the background (response to PBMC in the culture medium only) from 
the antigen response. Data points are the magnitudes of response to each antigen preparation at various time points. The dot-
ted lines indicate the cut-off value for ESAT-6 (70 IFN-γ SFC/106 PBMC).
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